Free Trial
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$25.44 +1.51 (+6.31%)
(As of 12/17/2024 ET)

About STAAR Surgical Stock (NASDAQ:STAA)

Key Stats

Today's Range
$24.09
$25.66
50-Day Range
$23.93
$33.00
52-Week Range
$23.72
$52.68
Volume
832,946 shs
Average Volume
702,856 shs
Market Capitalization
$1.25 billion
P/E Ratio
57.82
Dividend Yield
N/A
Price Target
$42.83
Consensus Rating
Hold

Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
93rd Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 93% of companies evaluated by MarketBeat, and ranked 103rd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    STAAR Surgical has only been the subject of 3 research reports in the past 90 days.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow by 183.33% in the coming year, from $0.12 to $0.34 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is 57.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.49.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is 57.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 128.22.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 3.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.60% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 2.47%, indicating that investor sentiment is improving.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.60% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 2.47%, indicating that investor sentiment is improving.
  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for STAAR Surgical this week, compared to 4 articles on an average week.
  • Search Interest

    Only 6 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.00% of the stock of STAAR Surgical is held by insiders.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

Analysts Set STAAR Surgical (NASDAQ:STAA) PT at $42.83
Hiding in the Bible
New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.
Staar Surgical price target lowered to $28 from $31 at Canaccord
Staar Surgical price target lowered to $23 from $27 at Morgan Stanley
Staar Surgical Co (STAA) Shares Down 3.45% on Dec 2
STAAR Surgical to Participate in BTIG Ophthalmology Day
STAAR Surgical: Turning A Blind Eye
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $31.21 at the start of the year. Since then, STAA stock has decreased by 18.5% and is now trading at $25.44.
View the best growth stocks for 2024 here
.

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings results on Wednesday, August, 7th. The medical instruments supplier reported $0.15 EPS for the quarter, missing analysts' consensus estimates of $0.24 by $0.09. The business's quarterly revenue was up 7.3% compared to the same quarter last year.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

Top institutional investors of STAAR Surgical include State Street Corp (3.94%), Baillie Gifford & Co. (2.96%), Geode Capital Management LLC (2.38%) and Geneva Capital Management LLC (1.41%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, James E Francese, Keith Holliday and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/07/2024
Today
12/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
1,115
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$42.83
High Stock Price Target
$55.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+68.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
9 Analysts

Profitability

Net Income
$21.35 million
Pretax Margin
10.26%

Debt

Sales & Book Value

Annual Sales
$341.22 million
Cash Flow
$0.75 per share
Book Value
$7.91 per share

Miscellaneous

Free Float
48,783,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
0.59

Social Links


This page (NASDAQ:STAA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners